EUVIMEDOpdag EUVIMED
Crossref

Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach

Balasubramanian Haridevamuthu iD, Gokul Sudhakaran iD, Raman Pachaiappan iD, Muthu Kumaradoss Kathiravan iD, Krishnan Manikandan iD, Mikhlid H Almutairi iD, Bader O Almutairi iD, Selvaraj Arokiyaraj iD, Jesu Arockiaraj iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16382 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Balasubramanian Haridevamuthu and 8 co-authors. Institution: Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tam…. Major MEDLINE topics: Zebrafish, Isoflavones, Behavior, Animal, Manganese. Cited 16 times so far (Crossref); 69 references. Funded by: Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Parkinson's disease (PD) is a prevalent neurodegenerative movement disorder characterized by motor dysfunction. Environmental factors, especially manganese (Mn), contribute significantly to PD. Existing therapies are focused on motor coordination, whereas nonmotor features such as neuropsychiatric symptoms are often neglected. Daidzein (DZ), a phytoestrogen, has piqued interest due to its antioxidant, anti‐inflammatory, and anxiolytic properties. Therefore, we anticipate that DZ might be an effective drug to alleviate the nonmotor symptoms of Mn‐induced Parkinsonism. Experimental Approach Naïve zebrafish were exposed to 2 mM of Mn for 21 days and intervened with DZ. Nonmotor symptoms such as anxiety, social behaviour, and olfactory function were assessed. Acetylcholinesterase (AChE) activity and antioxidant enzyme status were measured from brain tissue through biochemical assays. Dopamine levels and histology were performed to elucidate neuroprotective mechanism of DZ. Key Results DZ exhibited anxiolytic effects in a novel environment and also improved intra and inter fish social behaviour. DZ improved the olfactory function and response to amino acid stimuli in Mn‐induced Parkinsonism. DZ reduced brain oxidative stress and AChE activity and prevented neuronal damage. DZ increased DA level in the brain, collectively contributing to neuroprotection. Conclusion and Implications DZ demonstrated a promising effect on alleviating nonmotor symptoms such as anxiety and olfactory dysfunction, through the mitigation of cellular damage. These findings underscore the therapeutic potential of DZ in addressing nonmotor neurotoxicity induced by heavy metals, particularly in the context of Mn‐induced Parkinsonism.

Subjects

MeSH terms (MEDLINE)

ZebrafishIsoflavonesBehavior, AnimalManganeseDisease Models, AnimalParkinsonian DisordersAnimalsAcetylcholinesteraseDopamineOxidative StressBrainNeuroprotective AgentsMaleAnxietySocial Behavior

Author keywords

Parkinsonismanxiolytic effectdaidzeinnonmotor symptomsphytoestrogen

Substances

IsoflavonesManganesedaidzeinAcetylcholinesteraseDopamineNeuroprotective Agents

Authors and institutions

  • Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, 600105, India.
  • Department of Biotechnology, School of Bioengineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, 603203, India.
  • Dr APJ Abdul Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, 603203, India.
  • Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, 603203, India.
  • Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
  • Department of Food Science & Biotechnology, Sejong University, Seoul, 05006, Korea.

ORCID profiles: Balasubramanian Haridevamuthu, Gokul Sudhakaran, Raman Pachaiappan, Muthu Kumaradoss Kathiravan, Krishnan Manikandan, Mikhlid H Almutairi, Bader O Almutairi, Selvaraj Arokiyaraj, Jesu Arockiaraj

Funding

  • Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia

Cite

APA

Haridevamuthu, B., Sudhakaran, G., Pachaiappan, R., Kathiravan, M. K., Manikandan, K., Almutairi, M. H., Almutairi, B. O., Arokiyaraj, S., & Arockiaraj, J. (2024). Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach. British Journal of Pharmacology. https://doi.org/10.1111/bph.16382

Vancouver

Haridevamuthu B, Sudhakaran G, Pachaiappan R, Kathiravan MK, Manikandan K, Almutairi MH, et al. Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach. British Journal of Pharmacology. 2024. doi:10.1111/bph.16382

BibTeX
@article{Haridevamuthu2024,
  author = {Haridevamuthu, Balasubramanian and Sudhakaran, Gokul and Pachaiappan, Raman and Kathiravan, Muthu Kumaradoss and Manikandan, Krishnan and Almutairi, Mikhlid H and Almutairi, Bader O and Arokiyaraj, Selvaraj and Arockiaraj, Jesu},
  title = {Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16382}
}
Start for free →